tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ALXO is currently covered by 4 analysts with an average price target of $12.21. This is a potential upside of $10.19 (504.46%) from yesterday's end of day stock price of $2.02.
Alx Oncology Holdings 's activity chart (see below) currently has 72 price targets and 71 ratings on display. The stock rating distribution of ALXO is 83.33% BUY and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 29.76% with an average time for these price targets to be met of 107.33 days.
Highest price target for ALXO is $6, Lowest price target is $1, average price target is $3.5.
Most recent stock forecast was given by MICHAEL YEE from JEFFERIES on 06-Mar-2026. First documented stock forecast 11-Aug-2020.
Currently out of the existing stock ratings of ALXO, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Mar-2025
$6
$3.87 (181.69%)
$3
7 days ago
(06-Mar-2026)
2/8 (25%)
$3.87 (181.69%)
191
Buy Since 01-Mar-2022
$2
9 months 14 days ago
(27-May-2025)
3/9 (33.33%)
$1.58 (376.19%)
184
Buy Since 06-Apr-2021
$1
$-1.13 (-53.05%)
$2.2
9 months 20 days ago
(21-May-2025)
2/7 (28.57%)
$0.59 (143.90%)
235
Hold Since 09-Aug-2024
$1.5
$-0.63 (-29.58%)
1 years 6 days ago
(07-Mar-2025)
4/7 (57.14%)
$0.44 (41.51%)
249
Buy Since 11-Aug-2020
$21
1 years 7 days ago
(06-Mar-2025)
4/7 (57.14%)
$12.33 (142.21%)
54
What is ALXO (Alx Oncology Holdings ) average time for price targets to be met?
Which analyst has the current highest performing score on ALXO (Alx Oncology Holdings ) with a proven track record?
Which analyst has the current lower performing score on ALXO (Alx Oncology Holdings ) with a proven track record?
Which analyst has the most public recommendations on ALXO (Alx Oncology Holdings )?
Which analyst is the currently most bullish on ALXO (Alx Oncology Holdings )?
Which analyst is the currently most reserved on ALXO (Alx Oncology Holdings )?
